Large scale purification of human blood CD34(+) cells using a nylon-fiber syringe system and immunomagnetic microspheres

Background: To establish an available, economical technique for the large-s cale purification of CD34(+) cells we used a nylon-fiber syringe (NF-S) for depletion of adherent cells and then selected CD34(+) cells from periphera l blood mobilized by G-CSF, using MAb and magnetic beads. Methods: PBSC were mobilized and collected from adult, healthy volunteers. With the effect of concentration of anti-CD34 MAb (9C5) on the purification of CD34(+) cells from 1 x 10(8) NF-S treated cells (NF cells), the recover y and the purity of CD34(+) cells was identical for 5, 10, 20, 40 mu g of 9 C5. In this study, therefore, the concentration of 9C5 was maintained at >5 mu g/10(8) NF cells, with a cellbead ratio of 1:10. Results: When half to one-third of leukapheresis product containing 12.5 +/ - 26.0 x 10(8) mononuclear cells (mean +/- SD; n = 6) was processed for CD3 4(+) cell purification, 5.26 +/- 3.01 x 10(7) total purified cells were obt ained with a purity of CD34(+) cells at 94.9 +/- 8.5%. The numbers of CD34( +) cells and progenitor cells recovered in this process were 4.71 +/- 2.33 x 10(7) cells and 145.9 +/- 121.8 x 10(5) cells, respectively. The total re covery of CD34(+) cells was 37.0 +/- 21.0%. The depletion of monocyte by NF -S reduced the 9C5 anti-human CD34 MAb needed for purification of CD34(-) c ells to one-third. Two patients were grafted with peripheral blood CD34(+) cells selected by this procedure and achieved a rapid and consistent hemato poiesis. Discussion: Our clinical data show that these cells are capable of rapid re constitution of hematopoiesis after high-dose chemotherapy. The procedure c ontains an additional step; however, consistent high purity of CD34(+) cell s in the purified population and cost reduction were achieved, both critica l issues in the better purging of malignant cells and for a wide clinical a pplication.